Indepentednt logo

Lowering cholesterol levels reduces CVD mortality

Dr Alan BeggDr Alan Begg discusses how the NICE technology appraisal on ezetimibe will make it easier for GPs to reach QOF cholesterol targets

Chair of the SIGN stable angina guideline development group and a member of the SIGN CHD Steering Group

Published online: 01 January 2008

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Need help? Email us